NASDAQ:GLUE | Insider Transactions — Page 2 | Monte Rosa Therapeutics, Inc.

GLUE Insider Transactions — Page 2

109 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–109; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
NEA Partners 17, L.P.TenPercentOwner2021-06-28Purchase1,050,000.0$19.0
NEA 17 GP, LLCTenPercentOwner2021-06-28Purchase1,050,000.0$19.0
Bolzon Bradley J PhDDirector,TenPercentOwner2021-06-28Purchase157,895.0$19.0
Versant Venture Capital VI, L.P.TenPercentOwner2021-06-28Purchase157,895.0$19.0
Versant Vantage I, L.P.TenPercentOwner2021-06-28Purchase157,895.0$19.0
Versant Vantage I GP, L.P.TenPercentOwner2021-06-28Purchase157,895.0$19.0
Versant Ventures VI GP-GP, LLCTenPercentOwner2021-06-28Purchase157,895.0$19.0
Versant Vantage I GP-GP, LLCTenPercentOwner2021-06-28Purchase157,895.0$19.0
Versant Ventures VI GP, L.P.TenPercentOwner2021-06-28Purchase157,895.0$19.0